Inmune Bio, Inc. (INMB) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | SAPIRSTEIN JAMES Director | $0 | 100,000 | 0% | No | |
|
|
||||||
| July 7, 2026 filed July 2, 2026 | Juda Scott Director | $22,572 | 29,602 | +1480100% | No | |
|
|
||||||
| July 7, 2026 filed July 2, 2026 | Lowdell Mark William Chief Scientific Officer | $10,997 | 14,422 | +721100% | No | |
|
|
||||||
| July 7, 2026 filed July 2, 2026 | Moss David J Chief Executive Officer | $13,746 | 18,028 | New | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free